Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis

Experimental and Therapeutic Medicine

Volumn 3, Issue 6, 2012, Pages 1072-1076

  Shen, Yong Chun ^a   Liu, Meng Qi ^b   Wan, Chun ^a   Chen, Lei ^a   Wang, Tao ^a   Wen, Fu Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Malignant pleural effusion; Meta analysis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; EMBASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; MEDLINE; META ANALYSIS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84859475761     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.514     Document Type: Review

References (52)

1. McGrath EE and Anderson PB: Diagnosis of pleural effusion: a systematic approach. Am J Crit Care 20: 119-127, 2011.
2. Bennett R and Maskell N: Management of malignant pleural effusions. Curr Opin Pulm Med 11: 296300, 2005.
3. Prakash UB and Reiman HM: Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 60: 158164, 1985.
4. Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G and Pastorelli D: Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches. Am J Clin Oncol 33: 420423, 2010.
5. Shi HZ, Liang QL, Jiang J, Qin XJ and Yang HB: Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a metaanalysis. Respirology 13: 518527, 2008.
6. Liang QL, Shi HZ, Qin XJ, Liang XD, Jiang J and Yang HB: Diagnostic accuracy of tumour markers for malignant pleural effusion: a metaanalysis. Thorax 63: 3541, 2008.
7. Senger DR, Van de Water L, Brown LF, et al: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12: 303-324, 1993.
8. Berse B, Brown LF, Van de Water L, Dvorak HF and Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3: 211-220, 1992.
9. Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB Jr and Ellis LM: Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 5: 33643368, 1999.
10. Kraft A, Weindel K, Ochs A, et al: Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85: 178187, 1999.
11. Ishimoto O, Saijo Y, Narumi K, et al: High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer. Oncology 63: 7075, 2002.
12. Lim SC, Jung SI, Kim YC and Park KO: Vascular endothelial growth factor in malignant and tuberculous pleural effusions. JKorean Med Sci 15: 279283, 2000.
13. Hamed EA, El-Noweihi AM, Mohamed AZ and Mahmoud A: Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions. Respirology 9: 8186, 2004.
14. Kishiro I, Kato S, Fuse D, Yoshida T, Machida S and Kaneko N: Clinical significance of vascular endothelial growth factor in patients with primary lung cancer. Respirology 7: 9398, 2002.
15. Bossuyt PM, Reitsma JB, Bruns DE, et al: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 49: 1-6, 2003.
16. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM and Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25, 2003.
17. Jones CM, Ashrafian H, Skapinakis P, Arora S, Darzi A, Dimopoulos K and Athanasiou T: Diagnostic accuracy meta-analysis: a review of the basic principles of interpretation and application. Int J Cardiol 140: 138144, 2010.
18. Moses LE, Shapiro D and Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12: 1293-1316, 1993.
19. DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177188, 1986.
20. Lijmer JG, Bossuyt PM and Heisterkamp SH: Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 21: 1525-1537, 2002.
21. Koniari I, Koletti B and Apostolakis E: Vascular endothelial growth factor with tumour growth factor-beta, endostatin, proteinases or cytokines might be useful for differential diagnosis of pleural effusions. Interact Cardiovasc Thorac Surg 12: 424-425, 2011.
22. Kiropoulos TS, Kostikas K and Gourgoulianis KI: Vascular endothelial growth factor levels in pleural fluid and serum of patients with tuberculous pleural effusions. Chest 128: 468, 2005.
23. Economidou F, Antoniou KM, Soufla G, et al: Role of VEGF-stromal cellderived factor1alpha/CXCL12 axis in pleural effusion of lung cancer. J Recept Signal Transduct Res 30: 154-160, 2010.
24. Kotyza J, Havel D, Vrzalová J, Kulda V and Pesek M: Diagnostic and prognostic significance of inflammatory markers in lung cancer-associated pleural effusions. Int J Biol Markers 25: 12-20, 2010.
25. Bunatova K, Obermajer N, Kotyza J, Pesek M and Kos J: Levels of cathepsins S and H in pleural fluids of inflammatory and neoplastic origin. Int J Biol Markers 24: 47-51, 2009.
26. Economidou F, Antoniou KM, Tzanakis N, Sfiridaki K, Siafakas NM and Schiza SE: Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respir Med 102: 774779, 2008.
27. Atanackovic D, Cao Y, Kim JW, et al: The local cytokine and chemokine milieu within malignant effusions. Tumour Biol 29: 93104, 2008.
28. Tomimoto H, Yano S, Muguruma H, Kakiuchi S and Sone S: Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions. J Med Invest 54: 146-153, 2007.
29. Daniil ZD, Zintzaras E, Kiropoulos T, Papaioannou AI, Koutsokera A, Kastanis A and Gourgoulianis KI: Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J 30: 957-964, 2007.
30. Yeh HH, Lai WW, Chen HH, Liu HS and Su WC: Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 25: 4300-4309, 2006.
31. Kalomenidis I, Kollintza A, Sigala I, Papapetropoulos A, Papiris S, Light RW and Roussos C: Angiopoietin-2 levels are elevated in exudative pleural effusions. Chest 129: 1259-1266, 2006.
32. Ruiz E, Alemán C, Alegre J, etal: Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions. Lung 183: 185195, 2005.
33. Jin HY, Lee KS, Jin SM and Lee YC: Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion. Respir Med 98: 115122, 2004.
34. Davidson B, Vintman L, Zcharia E, et al: Heparanase and basic fibroblast growth factor are coexpressed in malignant mesothelioma. Clin Exp Metastasis 21: 469-476, 2004.
35. van Hensbergen Y, Broxterman HJ, Hanemaaijer R, et al: Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid. Clin Cancer Res 8: 37473754, 2002.
36. J Strizzi L, Catalano A, Vianale G, et al: Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol 193: 468475, 2001.
37. Verheul HM, Hoekman K, Jorna AS, Smit EF and Pinedo HM: Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation. Oncologist 5 (Suppl 1): 4550, 2000.
38. Cheng D, Lee YC, Rogers JT, Perkett EA, Moyers JP, Rodriguez RM and Light RW: Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions. Chest 118: 17471753, 2000.
39. Yanagawa H, Takeuchi E, Suzuki Y, Ohmoto Y, Bando H and Sone S: Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer. Cancer Immunol Immunother 48: 396400, 1999.
40. Thickett DR, Armstrong L and Millar AB: Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 54: 707-710, 1999.
41. Cheng D, Rodriguez RM, Perkett EA, Rogers J, Bienvenu G, Lappalainen U and Light RW: Vascular endothelial growth factor in pleural fluid. Chest 116: 760765, 1999.
42. Yeo KT, Wang HH, Nagy JA, et al: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53: 29122918, 1993.
43. Momi H, Matsuyama W, Inoue K, Kawabata M, Arimura K, Fukunaga H and Osame M: Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir Med 96: 817822, 2002.
44. Sack U, Hoffmann M, Zhao XJ, et al: Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 25: 600-604, 2005.
45. Shu J, Sun G, Liu H and Liu J: Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions. Acta Oncol 46: 10041011, 2007.
46. Xue K, Xiong S and Xiong W: Clinical value of vascular endothelial growth factor combined with interferon-gamma in diagnosing malignant pleural effusion and tuberculous pleural effusion. J Huazhong Univ Sci Technolog Med Sci 27: 495-497, 2007.
47. Cheng M, Chen Y, Yu X, Tian Z and Wei H: Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary nonsmall cell lung cancer. BMC Cancer 8: 156, 2008.
48. Duysinx BC, Corhay JL, Hubin L, Nguyen D, Henket M and Louis R: Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions. Respir Med 102: 17081714, 2008.
49. Zhou WB, Bai M and Jin Y: Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions. Int J Tuberc Lung Dis 13: 381386, 2009.
50. Chen Y, Liang B, Zhao YJ, Wang SC, Fan YB and Wu GP: Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer. Diagn Cytopathol: Oct. 26, 2010 (Epub ahead of print). doi: 10.1002/dc.21546.
51. Fiorelli A, Vicidomini G, Di Domenico M, etal: Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications. Interact Cardiovasc Thorac Surg 12: 420-424, 2011.
52. Glas AS, Lijmer JG, Prins MH, Bonsel GJ and Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135, 2003.